Fas ligand is required for the development of respiratory syncytial virus vaccine-enhanced disease. [electronic resource]
Producer: 20090421Description: 3024-31 p. digitalISSN:- 1550-6606
- Adjuvants, Immunologic -- administration & dosage
- Animals
- Autoimmune Diseases -- genetics
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Cell Differentiation -- genetics
- Epitopes, T-Lymphocyte -- immunology
- Fas Ligand Protein -- biosynthesis
- Humans
- Immunization, Secondary
- Immunologic Memory -- genetics
- Lymphatic Diseases -- genetics
- Mice
- Mice, Inbred BALB C
- Mice, Mutant Strains
- Pulmonary Eosinophilia -- genetics
- Respiratory Syncytial Virus Vaccines -- administration & dosage
- Respiratory Syncytial Viruses -- immunology
- Viral Envelope Proteins -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.